BetMakers Technology [ASX:BET] Talk Restructure and Profitability
BetMakers executes strategic operational restructure and accelerates path to profitability, sending shares 20% higher on the stockmarket today.
BetMakers executes strategic operational restructure and accelerates path to profitability, sending shares 20% higher on the stockmarket today.
By Mahlia Stewart,
Biotech Aroa has released its audited results for the 2023 financial year, hitting targets and achieving its expectations. The company looks ahead with a positive perspective on FY24, with the group providing new guidance today.
By Mahlia Stewart,
DroneShield has ramped up operations and production with numerous orders in the pipeline and having received $13.9 million in cash receipts, with a further $2 million coming in tax incentives.
By Mahlia Stewart,
Retail giant Wesfarmers has released a businesses health report, assessing the current environment and analysing strategies to make the most of current conditions.
By Mahlia Stewart,
ALS has reported underlying NPAT of $321 million for FY2023 — an increase of 23.4% on last year thanks to high-performing divisions.
By Mahlia Stewart,
Financial solutions business SmartPay Holdings has returned a 62% increase in revenue on the prior year with $77.8 million, with earnings up 81% and higher profit. Shares were riding in response to the bumper year.
By Mahlia Stewart,
Biotech company Mesoblast has released its Q3 financial report, saying that it cut losses after tax to US$18.6 million from US$21.3 million a year ago. Shares rose more than 4% during the group’s quarter improvement.
By Mahlia Stewart,
Chair of Appen Richard Freudenstein cast a sobering reflection on the group’s most recent performance, and over the broader technology industry, stating at the company’s AGM that 2022 was ‘far from satisfactory’.
By Mahlia Stewart,
FPH experienced a 34% slump in net profit in FY23, and shares were falling more than 4% in the hours that followed the news.
By Mahlia Stewart,
Universal Store has upgraded its guidance on group sales to be in the range of $258 million to $261 million for FY23 with underlying EBIT also higher yet shareholders were downvoting shares by more than 27% on a bleak spending outlook.
By Mahlia Stewart,
Investment ideas from the edge of the bell curve.
Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.
All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.
The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988